Journals / Diagnostic and Interventional Radiology / 2021 / Cilt: 27 - Sayı: 2

Diagnostic performance of low-dose chest CT to detect COVID-19: A Turkish population study

Pages
181–187
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We suggest that patients with typical CTfindings but negative rRT-PCR results should be isolated, and rRT-PCR should be repeated toavoid misdiagnosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:PURPOSEWe aimed to evaluate the diagnostic performance of low-dose chest computed tomography(CT) in patients under investigation for coronavirus disease 2019 (COVID-19).METHODSThis retrospective study included 330 patients suspected of having COVID-19 from March 15 toApril 16, 2020.
📊
Key Findings & Data:We examined 306 patients upon initial presentation using both CT and real-timereverse-transcriptase polymerase-chain-reaction (rRT-PCR).
💡
Conclusion & Impact:We suggest that patients with typical CTfindings but negative rRT-PCR results should be isolated, and rRT-PCR should be repeated toavoid misdiagnosis.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Özet

PURPOSEWe aimed to evaluate the diagnostic performance of low-dose chest computed tomography(CT) in patients under investigation for coronavirus disease 2019 (COVID-19).METHODSThis retrospective study included 330 patients suspected of having COVID-19 from March 15 toApril 16, 2020. We examined 306 patients upon initial presentation using both CT and real-timereverse-transcriptase polymerase-chain-reaction (rRT-PCR). The diagnostic performance of CTwas calculated using rRT-PCR as a reference. Clinical and laboratory data, CT characteristics, andlesion distribution were assessed for patients with a confirmed diagnosis via rRT-PCR.RESULTSA total of 250 patients were finally diagnosed with COVID-19. Clinical and laboratory findingsincluded myalgia or fatigue (76%), fever (64.8%), dry cough (60.8%), elevated levels of C-reactiveprotein (86.4%), procalcitonin (62%), and D-dimer (58.2%), increased neutrophil-lymphocyte ratio (NLR) (54.8%), and lymphopenia (34%). Sensitivity, specificity, positive predictive value (PPV)and negative predictive value (NPV) of the initial CT scan were 90.4% (95% IC, 86%–93%), 64.2%(95% IC, 50%–76%), 91.8% (95% IC, 88%–94%), and 60% (95% IC, 49%–69%), respectively. Thepercentage of patients diagnosed on the initial rRT-PCR test was 51.6% (n=129). Most frequentCT characteristics of COVID-19 in the subgroup of rRT-PCR-positive patients were multiple lesion(97.4%, n=220), followed by bilateral involvement (88.5%, n=200), peripheral distribution (74.3%,n=168), ground-glass opacity (GGO) (69.2%, n=157), subpleural curvilinear opacity (41.6%,n=104), and mixed GGOs (27.6%, n=67).CONCLUSIONrRT-PCR may produce initial false negative results. For this reason, typical CT findings forCOVID-19 should be known especially by radiologists. We suggest that patients with typical CTfindings but negative rRT-PCR results should be isolated, and rRT-PCR should be repeated toavoid misdiagnosis.

🔖

Cite This Article

ASLAN, S., BEKÇİ, T., ÇAKIR, İ. M., EKİZ, M., YAVUZ, İ., ŞAHİN, A. M. (2021). Diagnostic performance of low-dose chest CT to detect COVID-19: A Turkish population study. Diagnostic and Interventional Radiology, Cilt: 27 - Sayı: 2, 181–187. https://ajindex.com/articles/345575

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. World Health Organization. Pneumonia of unknown cause: China. World Health Organization, Geneva Available via www.who.int/csr/ don/05-january-2020-pneumonia-of-unkowncause-china/en/. Accessed February 13th, 2020
  2. Lu R, Zhao X, Li J et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020; 395:565–574. [Crossref] 3. World Health Organization main website. https:// www.who.int. Accessed March 12th, 2020
  3. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020; 382:727–733. [Crossref] 5. Long C, Xu H, Shen Q, et al Diagnosis of the coronavirus disease (COVID-19): rRT-PCR or CT? Eur J Radiol 2020; 126:108961. [Crossref] 6. Jin YH, Cai L, Cheng ZS, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version) Mil Med Res 2020; 7:4
  4. Pan Y, Guan H, Zhou S, et al. Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China. Eur Radiol. 2020 Feb 13. [Epub Ahead of Print] [Crossref] 8. Corman VM, Landt O, Kaiser M, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill 2020; 25:2000045. [Crossref] 9. Huang P, Liu T, Huang L, et al. Use of chest CT in combination with negative RT-PCR assay for the 2019 novel coronavirus but high clinical suspicion. Radiology 2020; 295:22–23. [Crossref] 10. Xie X, Zhong Z, Zhao W, et al. Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing. Radiology 2020 Feb 12. [Epub Ahead of Print] 11. Hansell DM, Bankier AA, MacMahon H, et al. Fleischner Society: glossary of terms for thoracic imaging. Radiology 2008; 246:697–722. [Crossref] 12. Li Q, Guan X, Wu P et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020; 382:1199–1207. [Crossref] 13. Kim EA, Lee KS, Primack SL et al. Viral pneumonias in adults: radiologic and pathologic findings. Radiographics 2002; Spec:S137–149. [Crossref] 14. Chung M, Bernheim A, Mei X, et al. CT Imaging Features of 2019 Novel Coronavirus (2019- nCoV). Radiology 2020; 295:202–207. [Crossref] 15. Diao K, Han P, Pang T, et al. HRCT imaging features in representative imported cases of 2019 novel coronavirus pneumonia. Precis Clin Med 2020; 3: 9–13. [Crossref] 16. Song F, Shi N, Shan F, et a